{"id":"EBD729D5-84FC-4806-A666-B137E31FAD0E","title":"Privileged Metallocene Catalysts for Asymmetric Synthesis","abstractText":"Bulky cobalt metallocenes have recently found application in a number of asymmetric transformations characterised by high enantioselectivity. The further development of this area is hampered by the absence of a general methodology for the synthesis of planar chiral derivatives. A general solution to this problem is proposed involving asymmetric desymmetrisation by either metal catalysed cross-coupling and/or enantioselective halogen-metal exchange. The resulting non-racemic products will be used for the synthesis of representative P, PN and PP ligands, and also for the generation of palladium based and 'organocatalytic' rearrangement catalysts for application in asymmetric synthesis.","grantUrl":"http://gtr.rcuk.ac.uk/projects?ref=EP/E06356X/1","grantId":"EP/E06356X/1","fundValue":"183239","fundStart":"2008-01-10","fundEnd":"2010-03-09","funder":"EPSRC","impactText":"  New methodology was established for the synthesis of chiral organometallic structures that were in turn used for the synthesis of novel catalysts. These enable the highly selective synthesis of organic building blocks for the generation of bioactive compounds. Chemicals,Pharmaceuticals and Medical Biotechnology Cultural,Societal,Economic","person":"Chris  Richards","coPersons":[],"organisation":"University of East Anglia","findingsText":" Bulky cobalt metallocenes have recently found application in a number of asymmetric transformations characterised by high enantioselectivity. The further development of this area is hampered by the absence of a general methodology for the synthesis of planar chiral derivatives. A general solution to this problem is proposed involving asymmetric desymmetrisation by either metal catalysed cross-coupling and/or enantioselective halogen-metal exchange. The resulting non-racemic products will be used for the synthesis of representative P, PN and PP ligands. In addition, enantioselective palladation will be developed for the rapid assembly of new rearrangement catalysts for application in asymmetric synthesis. Catalysts developed have the potential to be used in several areas of organic chemistry for the discovery and manufacture of bioactive compounds. Chemicals,Pharmaceuticals and Medical Biotechnology","dataset":"gtr"}